 | • レポートコード：MRC2-11QY04158 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は副甲状腺障害のグローバル市場について調査・分析したレポートです。種類別（身体検査、臨床検査、脳波（EEG））市場規模、用途別（病院、診療所、診断センター、ドラッグストア、薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別副甲状腺障害の競争状況、市場シェア ・世界の副甲状腺障害市場：種類別市場規模 2015年-2020年（身体検査、臨床検査、脳波（EEG）） ・世界の副甲状腺障害市場：種類別市場規模予測 2021年-2026年（身体検査、臨床検査、脳波（EEG）） ・世界の副甲状腺障害市場：用途別市場規模 2015年-2020年（病院、診療所、診断センター、ドラッグストア、薬局） ・世界の副甲状腺障害市場：用途別市場規模予測 2021年-2026年（病院、診療所、診断センター、ドラッグストア、薬局） ・北米の副甲状腺障害市場分析：米国、カナダ ・ヨーロッパの副甲状腺障害市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの副甲状腺障害市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の副甲状腺障害市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの副甲状腺障害市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Abbott Laboratories、Alcon Laboratories、Amgen、Bayer Healthcare、Becton, Dickinson and Company、Eli Lilly、Ethicon ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Parathyroid disorders lead to abnormal levels of calcium in the blood that can cause brittle bones, kidney stones, fatigue, weakness, and other problems.
Patients with chronic kidney disease may develop secondary hyperparathyroidism with resultant chronic kidney disease-mineral and bone disorder. Hypoparathyroidism most often occurs after neck surgery; it can also be caused by autoimmune destruction of the glands and other less common problems. Evaluation of patients with abnormal serum calcium levels includes a history and physical examination; repeat measurement of serum calcium level; and measurement of creatinine, magnesium, vitamin D, and parathyroid hormone levels. The treatment for symptomatic primary hyperparathyroidism is parathyroidectomy. Management of asymptomatic primary hyperparathyroidism includes monitoring symptoms; serum calcium and creatinine levels; and bone mineral density. Patients with hypoparathyroidism require close monitoring and vitamin D (e.g., calcitriol) replacement.
Market Analysis and Insights: Global Parathyroid Disorders Market
The global Parathyroid Disorders market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Parathyroid Disorders Scope and Market Size
Parathyroid Disorders market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Parathyroid Disorders market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Abbott Laboratories
Alcon Laboratories
Amgen
Bayer Healthcare
Becton, Dickinson and Company
Eli Lilly
Ethicon
…
Market segment by Type, the product can be split into
Physical Examination
Laboratory Tests
Electroencephalogram (EEG)
Market segment by Application, split into
Hospitals
Clinics
Diagnostic Centers
Drug Stores
Pharmacies
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Parathyroid Disorders Revenue
1.4 Market by Type
1.4.1 Global Parathyroid Disorders Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Physical Examination
1.4.3 Laboratory Tests
1.4.4 Electroencephalogram (EEG)
1.5 Market by Application
1.5.1 Global Parathyroid Disorders Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Diagnostic Centers
1.5.5 Drug Stores
1.5.6 Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Parathyroid Disorders Market Perspective (2015-2026)
2.2 Global Parathyroid Disorders Growth Trends by Regions
2.2.1 Parathyroid Disorders Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Parathyroid Disorders Historic Market Share by Regions (2015-2020)
2.2.3 Parathyroid Disorders Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Parathyroid Disorders Market Growth Strategy
2.3.6 Primary Interviews with Key Parathyroid Disorders Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Parathyroid Disorders Players by Market Size
3.1.1 Global Top Parathyroid Disorders Players by Revenue (2015-2020)
3.1.2 Global Parathyroid Disorders Revenue Market Share by Players (2015-2020)
3.1.3 Global Parathyroid Disorders Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Parathyroid Disorders Market Concentration Ratio
3.2.1 Global Parathyroid Disorders Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Parathyroid Disorders Revenue in 2019
3.3 Parathyroid Disorders Key Players Head office and Area Served
3.4 Key Players Parathyroid Disorders Product Solution and Service
3.5 Date of Enter into Parathyroid Disorders Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Parathyroid Disorders Historic Market Size by Type (2015-2020)
4.2 Global Parathyroid Disorders Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Parathyroid Disorders Market Size by Application (2015-2020)
5.2 Global Parathyroid Disorders Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Parathyroid Disorders Market Size (2015-2020)
6.2 Parathyroid Disorders Key Players in North America (2019-2020)
6.3 North America Parathyroid Disorders Market Size by Type (2015-2020)
6.4 North America Parathyroid Disorders Market Size by Application (2015-2020)
7 Europe
7.1 Europe Parathyroid Disorders Market Size (2015-2020)
7.2 Parathyroid Disorders Key Players in Europe (2019-2020)
7.3 Europe Parathyroid Disorders Market Size by Type (2015-2020)
7.4 Europe Parathyroid Disorders Market Size by Application (2015-2020)
8 China
8.1 China Parathyroid Disorders Market Size (2015-2020)
8.2 Parathyroid Disorders Key Players in China (2019-2020)
8.3 China Parathyroid Disorders Market Size by Type (2015-2020)
8.4 China Parathyroid Disorders Market Size by Application (2015-2020)
9 Japan
9.1 Japan Parathyroid Disorders Market Size (2015-2020)
9.2 Parathyroid Disorders Key Players in Japan (2019-2020)
9.3 Japan Parathyroid Disorders Market Size by Type (2015-2020)
9.4 Japan Parathyroid Disorders Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Parathyroid Disorders Market Size (2015-2020)
10.2 Parathyroid Disorders Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Parathyroid Disorders Market Size by Type (2015-2020)
10.4 Southeast Asia Parathyroid Disorders Market Size by Application (2015-2020)
11 India
11.1 India Parathyroid Disorders Market Size (2015-2020)
11.2 Parathyroid Disorders Key Players in India (2019-2020)
11.3 India Parathyroid Disorders Market Size by Type (2015-2020)
11.4 India Parathyroid Disorders Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Parathyroid Disorders Market Size (2015-2020)
12.2 Parathyroid Disorders Key Players in Central & South America (2019-2020)
12.3 Central & South America Parathyroid Disorders Market Size by Type (2015-2020)
12.4 Central & South America Parathyroid Disorders Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Abbott Laboratories
13.1.1 Abbott Laboratories Company Details
13.1.2 Abbott Laboratories Business Overview
13.1.3 Abbott Laboratories Parathyroid Disorders Introduction
13.1.4 Abbott Laboratories Revenue in Parathyroid Disorders Business (2015-2020))
13.1.5 Abbott Laboratories Recent Development
13.2 Alcon Laboratories
13.2.1 Alcon Laboratories Company Details
13.2.2 Alcon Laboratories Business Overview
13.2.3 Alcon Laboratories Parathyroid Disorders Introduction
13.2.4 Alcon Laboratories Revenue in Parathyroid Disorders Business (2015-2020)
13.2.5 Alcon Laboratories Recent Development
13.3 Amgen
13.3.1 Amgen Company Details
13.3.2 Amgen Business Overview
13.3.3 Amgen Parathyroid Disorders Introduction
13.3.4 Amgen Revenue in Parathyroid Disorders Business (2015-2020)
13.3.5 Amgen Recent Development
13.4 Bayer Healthcare
13.4.1 Bayer Healthcare Company Details
13.4.2 Bayer Healthcare Business Overview
13.4.3 Bayer Healthcare Parathyroid Disorders Introduction
13.4.4 Bayer Healthcare Revenue in Parathyroid Disorders Business (2015-2020)
13.4.5 Bayer Healthcare Recent Development
13.5 Becton, Dickinson and Company
13.5.1 Becton, Dickinson and Company Company Details
13.5.2 Becton, Dickinson and Company Business Overview
13.5.3 Becton, Dickinson and Company Parathyroid Disorders Introduction
13.5.4 Becton, Dickinson and Company Revenue in Parathyroid Disorders Business (2015-2020)
13.5.5 Becton, Dickinson and Company Recent Development
13.6 Eli Lilly
13.6.1 Eli Lilly Company Details
13.6.2 Eli Lilly Business Overview
13.6.3 Eli Lilly Parathyroid Disorders Introduction
13.6.4 Eli Lilly Revenue in Parathyroid Disorders Business (2015-2020)
13.6.5 Eli Lilly Recent Development
13.7 Ethicon
13.7.1 Ethicon Company Details
13.7.2 Ethicon Business Overview
13.7.3 Ethicon Parathyroid Disorders Introduction
13.7.4 Ethicon Revenue in Parathyroid Disorders Business (2015-2020)
13.7.5 Ethicon Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Parathyroid Disorders Key Market Segments
Table 2. Key Players Covered: Ranking by Parathyroid Disorders Revenue
Table 3. Ranking of Global Top Parathyroid Disorders Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Parathyroid Disorders Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Physical Examination
Table 6. Key Players of Laboratory Tests
Table 7. Key Players of Electroencephalogram (EEG)
Table 8. Global Parathyroid Disorders Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Parathyroid Disorders Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Parathyroid Disorders Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Parathyroid Disorders Market Share by Regions (2015-2020)
Table 12. Global Parathyroid Disorders Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Parathyroid Disorders Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Parathyroid Disorders Market Growth Strategy
Table 18. Main Points Interviewed from Key Parathyroid Disorders Players
Table 19. Global Parathyroid Disorders Revenue by Players (2015-2020) (Million US$)
Table 20. Global Parathyroid Disorders Market Share by Players (2015-2020)
Table 21. Global Top Parathyroid Disorders Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Parathyroid Disorders as of 2019)
Table 22. Global Parathyroid Disorders by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Parathyroid Disorders Product Solution and Service
Table 25. Date of Enter into Parathyroid Disorders Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Parathyroid Disorders Market Size by Type (2015-2020) (Million US$)
Table 28. Global Parathyroid Disorders Market Size Share by Type (2015-2020)
Table 29. Global Parathyroid Disorders Revenue Market Share by Type (2021-2026)
Table 30. Global Parathyroid Disorders Market Size Share by Application (2015-2020)
Table 31. Global Parathyroid Disorders Market Size by Application (2015-2020) (Million US$)
Table 32. Global Parathyroid Disorders Market Size Share by Application (2021-2026)
Table 33. North America Key Players Parathyroid Disorders Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Parathyroid Disorders Market Share (2019-2020)
Table 35. North America Parathyroid Disorders Market Size by Type (2015-2020) (Million US$)
Table 36. North America Parathyroid Disorders Market Share by Type (2015-2020)
Table 37. North America Parathyroid Disorders Market Size by Application (2015-2020) (Million US$)
Table 38. North America Parathyroid Disorders Market Share by Application (2015-2020)
Table 39. Europe Key Players Parathyroid Disorders Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Parathyroid Disorders Market Share (2019-2020)
Table 41. Europe Parathyroid Disorders Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Parathyroid Disorders Market Share by Type (2015-2020)
Table 43. Europe Parathyroid Disorders Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Parathyroid Disorders Market Share by Application (2015-2020)
Table 45. China Key Players Parathyroid Disorders Revenue (2019-2020) (Million US$)
Table 46. China Key Players Parathyroid Disorders Market Share (2019-2020)
Table 47. China Parathyroid Disorders Market Size by Type (2015-2020) (Million US$)
Table 48. China Parathyroid Disorders Market Share by Type (2015-2020)
Table 49. China Parathyroid Disorders Market Size by Application (2015-2020) (Million US$)
Table 50. China Parathyroid Disorders Market Share by Application (2015-2020)
Table 51. Japan Key Players Parathyroid Disorders Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Parathyroid Disorders Market Share (2019-2020)
Table 53. Japan Parathyroid Disorders Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Parathyroid Disorders Market Share by Type (2015-2020)
Table 55. Japan Parathyroid Disorders Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Parathyroid Disorders Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Parathyroid Disorders Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Parathyroid Disorders Market Share (2019-2020)
Table 59. Southeast Asia Parathyroid Disorders Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Parathyroid Disorders Market Share by Type (2015-2020)
Table 61. Southeast Asia Parathyroid Disorders Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Parathyroid Disorders Market Share by Application (2015-2020)
Table 63. India Key Players Parathyroid Disorders Revenue (2019-2020) (Million US$)
Table 64. India Key Players Parathyroid Disorders Market Share (2019-2020)
Table 65. India Parathyroid Disorders Market Size by Type (2015-2020) (Million US$)
Table 66. India Parathyroid Disorders Market Share by Type (2015-2020)
Table 67. India Parathyroid Disorders Market Size by Application (2015-2020) (Million US$)
Table 68. India Parathyroid Disorders Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Parathyroid Disorders Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Parathyroid Disorders Market Share (2019-2020)
Table 71. Central & South America Parathyroid Disorders Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Parathyroid Disorders Market Share by Type (2015-2020)
Table 73. Central & South America Parathyroid Disorders Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Parathyroid Disorders Market Share by Application (2015-2020)
Table 75. Abbott Laboratories Company Details
Table 76. Abbott Laboratories Business Overview
Table 77. Abbott Laboratories Product
Table 78. Abbott Laboratories Revenue in Parathyroid Disorders Business (2015-2020) (Million US$)
Table 79. Abbott Laboratories Recent Development
Table 80. Alcon Laboratories Company Details
Table 81. Alcon Laboratories Business Overview
Table 82. Alcon Laboratories Product
Table 83. Alcon Laboratories Revenue in Parathyroid Disorders Business (2015-2020) (Million US$)
Table 84. Alcon Laboratories Recent Development
Table 85. Amgen Company Details
Table 86. Amgen Business Overview
Table 87. Amgen Product
Table 88. Amgen Revenue in Parathyroid Disorders Business (2015-2020) (Million US$)
Table 89. Amgen Recent Development
Table 90. Bayer Healthcare Company Details
Table 91. Bayer Healthcare Business Overview
Table 92. Bayer Healthcare Product
Table 93. Bayer Healthcare Revenue in Parathyroid Disorders Business (2015-2020) (Million US$)
Table 94. Bayer Healthcare Recent Development
Table 95. Becton, Dickinson and Company Company Details
Table 96. Becton, Dickinson and Company Business Overview
Table 97. Becton, Dickinson and Company Product
Table 98. Becton, Dickinson and Company Revenue in Parathyroid Disorders Business (2015-2020) (Million US$)
Table 99. Becton, Dickinson and Company Recent Development
Table 100. Eli Lilly Company Details
Table 101. Eli Lilly Business Overview
Table 102. Eli Lilly Product
Table 103. Eli Lilly Revenue in Parathyroid Disorders Business (2015-2020) (Million US$)
Table 104. Eli Lilly Recent Development
Table 105. Ethicon Company Details
Table 106. Ethicon Business Overview
Table 107. Ethicon Product
Table 108. Ethicon Revenue in Parathyroid Disorders Business (2015-2020) (Million US$)
Table 109. Ethicon Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Parathyroid Disorders Market Share by Type: 2020 VS 2026
Figure 2. Physical Examination Features
Figure 3. Laboratory Tests Features
Figure 4. Electroencephalogram (EEG) Features
Figure 5. Global Parathyroid Disorders Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Diagnostic Centers Case Studies
Figure 9. Drug Stores Case Studies
Figure 10. Pharmacies Case Studies
Figure 11. Parathyroid Disorders Report Years Considered
Figure 12. Global Parathyroid Disorders Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Parathyroid Disorders Market Share by Regions: 2020 VS 2026
Figure 14. Global Parathyroid Disorders Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Parathyroid Disorders Market Share by Players in 2019
Figure 17. Global Top Parathyroid Disorders Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Parathyroid Disorders as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Parathyroid Disorders Revenue in 2019
Figure 19. North America Parathyroid Disorders Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Parathyroid Disorders Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Parathyroid Disorders Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Parathyroid Disorders Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Parathyroid Disorders Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Parathyroid Disorders Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Parathyroid Disorders Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bottom-up and Top-down Approaches for This Report
Figure 27. Data Triangulation
Figure 28. Key Executives Interviewed
パニック障害の世界市場（～2026年） Panic disorder is an anxiety disorder characterized by reoccurring unexpected panic attacks. Panic disorder is usually treated with counselling and medications. The type of counselling used is typically cognitive behavioral therapy which is effective in more than half of people. Medications used inc…- 血液疾患診断・治療の世界市場（～2026年） Hematology, a branch of medicine, deals with the prevention, diagnosis, and treatment of blood diseases. It includes problems associated with red blood cells (RBCs), white blood cells (WBCs), platelets, bone marrow, blood vessels, spleen, lymph nodes, and proteins involved in bleeding and clotting p…
- 膝・股関節障害の世界市場（～2026年） Knee and hip are complex joints in the body. The knee joins the thigh bone (femur) to the shin bone (tibia), whereas the hip joint is a ball-socket synovial joint formed between the os coxa (hip bone) and the femur. To treat knee and hip disorders, implants and surgeries are performed so as to keep …
- 単遺伝性疾患検査の世界市場（～2026年） According to Mendel's Laws, the monogenetic disorders are inherited because of a single defective gene on the autosomes. The monogenic disorders are caused by single mutated gene which can be present on single or both chromosomes. Females and males are equally affected by this disorder due to the co…
- 骨・ミネラル代謝障害治療の世界市場（～2026年） Bone minerals are the inorganic compounds of the bone tissue that helps in strengthening the bones with its plate and globular structures. These minerals are formed from carbonated hydroxyapatite. Bone minerals are dynamic in living beings, it is continuously reabsorbed and build anew in the bone re…